NAMSW NewAmsterdam Pharma Company N.V.
Fundamentals / CIK 0001936258 / USDNewAmsterdam Pharma Company N.V. reported $25.94M in revenue and a net loss of $204.9M for the trailing twelve months ended September 30, 2026 (up 5406.9% year over year), with a -900.1% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open NAMSW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$25.94M +5406.9% YoY
-
Operating Income TTM-$233.5M -900.1% margin
-
Net Income TTM-$204.9M -789.9% net margin
-
Diluted EPS TTM-$1.65 Split-adjusted
-
Free Cash Flow TTM-$150.9M -581.6% FCF margin
-
Cash & ST Investments Sep 30, 2026$628.2M Total debt: $76K
Annual revenue and net income
5 fiscal years (2021 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Revenue | $22.50M | $45.56M | $14.09M | $102.7M | -- |
| Research & Development | $141.8M | $151.4M | $159.4M | $86.74M | $28.97M |
| Selling, General & Admin | $106.4M | $70.45M | $37.63M | $19.51M | $6.00M |
| Total Operating Expenses | $248.2M | $221.9M | $197.1M | $106.3M | $34.98M |
| Operating Income | -$225.7M | -$176.3M | -$183.0M | -$3.56M | -$34.98M |
| EBITDA | -$225.5M | -$176.2M | -$182.9M | -$3.55M | -$34.97M |
| Interest Income | $27.59M | $16.88M | $11.28M | -- | -- |
| Interest Expense | -- | -- | -- | $287K | $411K |
| Income Before Tax | -$203.8M | -$241.6M | -$176.9M | -$22.63M | -$41.78M |
| Income Tax Expense | -- | -$1.0K | $27K | -- | -- |
| Net Income | -$203.8M | -$241.6M | -$176.9M | -$22.63M | -$41.78M |
| Basic EPS | -$1.72 | -$2.56 | -$2.15 | -$1.19 | -$3.81 |
| Diluted EPS | -$1.72 | -$2.56 | -$2.15 | -$1.19 | -$3.81 |
| Basic Shares Outstanding | 118.4M | 94.4M | 82.2M | 19.0M | 11.0M |
| Diluted Shares Outstanding | 118.4M | 94.4M | 82.2M | 19.0M | 11.0M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19.16M | $3.70M | $3.04M | $32K | $348K | $19.14M | $2.98M | $12.77M |
| Research & Development | $39.36M | $41.67M | $38.01M | $38.59M | $30.97M | $27.52M | $44.75M | $34.90M |
| Selling, General & Admin | $24.00M | $26.89M | $23.45M | $27.42M | $24.52M | $27.26M | $27.15M | $21.11M |
| Total Operating Expenses | $63.35M | $68.56M | $61.46M | $66.01M | $55.49M | $54.78M | $71.90M | $56.00M |
| Operating Income | -$44.19M | -$64.86M | -$58.42M | -$65.98M | -$55.14M | -$35.63M | -$68.92M | -$43.23M |
| EBITDA | -$44.12M | -$64.81M | -$58.36M | -$65.92M | -$55.08M | -$35.59M | -$68.87M | -$43.18M |
| Interest Income | $5.19M | $5.81M | $5.65M | $6.47M | $6.71M | $7.05M | $7.35M | $4.49M |
| Income Before Tax | -$16.18M | -$64.14M | -$48.44M | -$74.92M | -$72.00M | -$17.36M | -$39.53M | -$92.18M |
| Income Tax Expense | $1.21M | -- | -- | -- | -- | -- | -- | -- |
| Net Income | -$17.39M | -$64.14M | -$48.44M | -$74.92M | -$72.00M | -$17.36M | -$39.53M | -$92.18M |
| Basic EPS | -$0.14 | -$0.52 | -$0.40 | -- | -$0.61 | -$0.15 | -$0.34 | -- |
| Diluted EPS | -$0.14 | -$0.52 | -$0.40 | -- | -$0.61 | -$0.15 | -$0.34 | -- |
| Basic Shares Outstanding | 124.1M | 123.4M | 121.7M | -- | 119.0M | 118.6M | 116.1M | -- |
| Diluted Shares Outstanding | 124.1M | 123.4M | 121.7M | -- | 119.0M | 118.6M | 116.1M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $490.0M | $771.7M | $340.4M | $467.7M |
| Short-Term Investments | $146.2M | $62.45M | -- | -- |
| Cash & Short-Term Investments | $636.2M | $834.2M | $340.4M | $467.7M |
| Total Current Assets | $675.7M | $863.4M | $346.8M | $478.0M |
| Property, Plant & Equipment, Net | $383K | $242K | $46K | $34K |
| Long-Term Investments | $92.61M | -- | -- | -- |
| Total Non-Current Assets | $93.58M | $1.21M | $306K | $518K |
| Total Assets | $769.3M | $864.6M | $347.1M | $478.5M |
| Accounts Payable | $8.97M | $4.74M | $16.92M | $11.85M |
| Deferred Revenue (Current) | $3.99M | $6.01M | $8.94M | $13.87M |
| Total Current Liabilities | $85.79M | $106.9M | $49.90M | $36.06M |
| Deferred Revenue (Non-Current) | -- | -- | $1.02M | $4.79M |
| Total Non-Current Liabilities | $66K | $202K | $8.81M | $12.37M |
| Total Liabilities | $85.85M | $107.1M | $58.70M | $48.43M |
| Total Debt (incl. Leases) | $202K | $448K | $60K | $126K |
| Common Stock | $14.28M | $13.44M | $10.17M | $10.05M |
| Retained Earnings | -$762.4M | -$558.6M | -$317.0M | -$140.0M |
| Accumulated Other Comp. Income | $4.79M | $4.47M | $4.42M | $4.42M |
| Total Stockholders' Equity | $683.4M | $757.5M | $288.4M | $430.1M |
| Total Equity | $683.4M | $757.5M | $288.4M | $430.1M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $423.1M | $424.2M | $457.6M | $490.0M | $538.4M | $563.9M | $748.4M | $771.7M |
| Short-Term Investments | $205.1M | $209.7M | $178.5M | $146.2M | $164.5M | $175.3M | $60.06M | $62.45M |
| Cash & Short-Term Investments | $628.2M | $633.9M | $636.1M | $636.2M | $702.9M | $739.2M | $808.5M | $834.2M |
| Total Current Assets | $672.2M | $659.2M | $658.0M | $675.7M | $732.3M | $769.9M | $817.3M | $863.4M |
| Property, Plant & Equipment, Net | $554K | $411K | $379K | $383K | $323K | $312K | $238K | $242K |
| Long-Term Investments | $14.88M | $44.41M | $71.24M | $92.61M | $53.09M | $44.17M | -- | -- |
| Total Non-Current Assets | $15.82M | $45.24M | $74.60M | $93.58M | $54.10M | $45.26M | $1.11M | $1.21M |
| Total Assets | $688.0M | $704.5M | $732.6M | $769.3M | $786.4M | $815.1M | $818.4M | $864.6M |
| Accounts Payable | $4.63M | $5.42M | $8.09M | $8.97M | $3.63M | $5.89M | $6.09M | $4.74M |
| Deferred Revenue (Current) | $5.71M | $2.80M | $3.99M | $3.99M | -- | -- | $3.03M | $6.01M |
| Total Current Liabilities | $57.15M | $72.97M | $67.42M | $85.79M | $58.27M | $36.51M | $40.91M | $106.9M |
| Total Non-Current Liabilities | $49K | $56K | $0 | $66K | $85K | $103K | $137K | $202K |
| Total Liabilities | $57.20M | $73.03M | $67.42M | $85.85M | $58.36M | $36.62M | $41.05M | $107.1M |
| Total Debt (incl. Leases) | $76K | $82K | $23K | $202K | $266K | $328K | $389K | $448K |
| Common Stock | $15.03M | $14.73M | $14.59M | $14.28M | $14.11M | $14.01M | $13.97M | $13.44M |
| Retained Earnings | -$892.4M | -$875.0M | -$810.8M | -$762.4M | -$687.5M | -$615.5M | -$598.1M | -$558.6M |
| Accumulated Other Comp. Income | $3.62M | $3.86M | $4.22M | $4.79M | $4.64M | $4.33M | $4.43M | $4.47M |
| Total Stockholders' Equity | $630.8M | $631.4M | $665.2M | $683.4M | $728.1M | $778.5M | $777.4M | $757.5M |
| Total Equity | $630.8M | $631.4M | $665.2M | $683.4M | $728.1M | $778.5M | $777.4M | $757.5M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Net Income | -$203.8M | -$241.6M | -$176.9M | -$22.63M | -$41.78M |
| Depreciation & Amortization | $220K | $113K | $49K | $9.0K | $5.0K |
| Stock-Based Compensation | $59.42M | $33.62M | $24.57M | $4.12M | $1.24M |
| Change in Payables | $4.91M | -$12.95M | $5.07M | $4.81M | $6.56M |
| Operating Cash Flow | -$147.8M | -$158.6M | -$141.2M | $10.66M | -$29.51M |
| Capital Expenditure | -$246K | -$672K | -$24K | -$221K | -$24K |
| Free Cash Flow | -$148.0M | -$159.2M | -$141.2M | $10.44M | -$29.54M |
| Purchases of Investments | -$296.7M | -$62.18M | -- | -- | -- |
| Investing Cash Flow | -$174.9M | -$62.85M | -$24K | -$221K | -$24K |
| Financing Cash Flow | $29.52M | $659.5M | $8.91M | $391.9M | $84.70M |
| Net Change in Cash | -$293.2M | $438.1M | -$132.3M | $402.3M | $55.17M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$17.39M | -$64.14M | -$48.44M | -$74.92M | -$72.00M | -$17.36M | -$39.53M | -$92.18M |
| Depreciation & Amortization | $67K | $59K | $62K | $59K | $64K | $45K | $52K | $51K |
| Stock-Based Compensation | $12.52M | $18.38M | $18.00M | $14.02M | $15.01M | $15.18M | $15.21M | $9.41M |
| Change in Payables | -$835K | -$2.69M | -$793K | $5.32M | -$2.27M | -$391K | $2.25M | -$3.20M |
| Operating Cash Flow | -$39.77M | -$39.21M | -$30.60M | -$40.88M | -$32.77M | -$37.67M | -$36.47M | -$37.48M |
| Capital Expenditure | -$177K | -$80K | -$38K | -$100K | -$42K | -$88K | -$16K | -$3.0K |
| Free Cash Flow | -$39.95M | -$39.29M | -$30.64M | -$40.98M | -$32.81M | -$37.76M | -$36.48M | -$37.48M |
| Purchases of Investments | -$13.01M | -$51.18M | -$62.47M | -$71.54M | -$31.85M | -$183.7M | -$9.63M | -- |
| Investing Cash Flow | $33.70M | -$4.76M | -$11.51M | -$21.14M | $2.51M | -$159.1M | $2.85M | -$62.18M |
| Financing Cash Flow | $5.45M | $11.04M | $11.06M | $13.68M | $5.89M | $3.42M | $6.52M | $456.6M |
| Net Change in Cash | -$623K | -$32.94M | -$31.05M | -$48.33M | -$24.37M | -$193.4M | -$27.09M | $357.0M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Operating Margin | -1002.9% | -386.9% | -1298.6% | -3.5% | -- |
| Net Profit Margin | -905.7% | -530.3% | -1255.8% | -22.0% | -- |
| Return on Equity (ROE) | -29.8% | -31.9% | -61.4% | -5.3% | -- |
| Return on Assets (ROA) | -26.5% | -27.9% | -51.0% | -4.7% | -- |
| Current Ratio | 7.88x | 8.08x | 6.95x | 13.26x | -- |
| Quick Ratio | 7.42x | 7.80x | 6.82x | 12.97x | -- |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.00x | -- |
| Revenue Growth (YoY) | -50.6% | +223.4% | -86.3% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -1424.1% | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -1452.4% | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -900.1% | -3432.2% | -953.6% | -1002.9% | -575.8% | -270.0% | -402.5% | -386.9% |
| Net Profit Margin | -789.9% | -3644.2% | -942.8% | -905.7% | -627.3% | -258.9% | -397.5% | -530.3% |
| Return on Equity (ROE) | -32.5% | -41.1% | -32.0% | -29.8% | -30.4% | -21.3% | -24.1% | -31.9% |
| Return on Assets (ROA) | -29.8% | -36.8% | -29.0% | -26.5% | -28.1% | -20.3% | -22.9% | -27.9% |
| Current Ratio | 11.76x | 9.03x | 9.76x | 7.88x | 12.57x | 21.08x | 19.98x | 8.08x |
| Quick Ratio | 10.99x | 8.69x | 9.43x | 7.42x | 12.06x | 20.24x | 19.76x | 7.80x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Revenue Growth (YoY) | +5406.9% | -80.7% | +2.1% | -99.7% | -98.8% | +740.1% | +112.6% | +1490.5% |